Valuation : IDEXX Laboratories, Inc.

Market Cap 42.95B 37.04B 34.85B 31.77B 59.68B 4,078B 60.1B 413B 160B 2,073B 161B 158B 6,879B P/E 2026 *
36.9x
P/E 2027 * 32.7x
Enterprise Value 43.32B 37.35B 35.15B 32.04B 60.19B 4,112B 60.61B 416B 162B 2,091B 163B 159B 6,938B EV / Sales 2026 *
9.17x
EV / Sales 2027 * 8.34x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : IDEXX Laboratories, Inc.

1 day-2.32%
1 week-0.81%
Current month-2.32%
1 month-1.18%
1 week 441.48
Extreme 441.4765
452.54
1 month 439.98
Extreme 439.9835
483.21
Current year 423.56
Extreme 423.5615
483.21
1 year 423.56
Extreme 423.5615
483.21
3 years 423.56
Extreme 423.5615
483.21
5 years 423.56
Extreme 423.5615
483.21
10 years 423.56
Extreme 423.5615
483.21
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Change 5-day change 1-year change 3-year change Capi.($)
-2.32%-0.81% - - 43.86B
-2.07%-2.56%-15.75%+6.60% 43.86B
Average -2.19%-0.35%-15.75%+6.60% 43.86B
Weighted average by Cap. -2.19%-0.35%-15.75%+6.60%

Financials

2026 *2027 *
Net sales 4.72B 4.07B 3.83B 3.49B 6.56B 449B 6.61B 45.41B 17.64B 228B 17.74B 17.35B 757B 5.14B 4.43B 4.17B 3.8B 7.14B 488B 7.19B 49.41B 19.2B 248B 19.3B 18.88B 823B
Net income 1.18B 1.02B 956M 872M 1.64B 112B 1.65B 11.33B 4.4B 56.9B 4.43B 4.33B 189B 1.31B 1.13B 1.07B 972M 1.83B 125B 1.84B 12.64B 4.91B 63.44B 4.93B 4.83B 211B
Net Debt 368M 317M 299M 272M 511M 34.94B 515M 3.54B 1.37B 17.76B 1.38B 1.35B 58.94B -97.34M -83.94M -78.98M -72.01M -135M -9.24B -136M -936M -364M -4.7B -365M -358M -15.59B
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change
26-09-01 CHF 442.03 -2.32%
26-08-31 CHF 452.54 +1.14%
26-08-28 CHF 447.43 +1.35%
26-08-27 CHF 441.48 -0.48%
26-08-26 CHF 443.61 +0.20%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
556.69USD
Average target price
698.92USD
Spread / Average Target
+25.55%

Quarterly revenue - Rate of surprise